Mycronic AB (publ)
MICLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7,057 | $5,706 | $5,119 | $4,635 |
| % Growth | 23.7% | 11.5% | 10.4% | – |
| Cost of Goods Sold | $3,338 | $2,850 | $2,831 | $2,351 |
| Gross Profit | $3,719 | $2,856 | $2,288 | $2,284 |
| % Margin | 52.7% | 50.1% | 44.7% | 49.3% |
| R&D Expenses | $747 | $653 | $638 | $548 |
| G&A Expenses | $73 | $338 | $32 | $18 |
| SG&A Expenses | $338 | $996 | $286 | $228 |
| Sales & Mktg Exp. | $265 | $658 | $254 | $210 |
| Other Operating Expenses | $621 | $0 | $469 | $459 |
| Operating Expenses | $1,706 | $1,649 | $1,393 | $1,235 |
| Operating Income | $2,013 | $1,207 | $894 | $997 |
| % Margin | 28.5% | 21.2% | 17.5% | 21.5% |
| Other Income/Exp. Net | $71 | $55 | -$3 | $49 |
| Pre-Tax Income | $2,084 | $1,262 | $891 | $1,046 |
| Tax Expense | $396 | $266 | $154 | $219 |
| Net Income | $1,683 | $998 | $741 | $828 |
| % Margin | 23.8% | 17.5% | 14.5% | 17.9% |
| EPS | 8.63 | 5.11 | 3.8 | 4.24 |
| % Growth | 68.9% | 34.5% | -10.4% | – |
| EPS Diluted | 8.62 | 5.11 | 3.8 | 4.24 |
| Weighted Avg Shares Out | 98 | 98 | 98 | 98 |
| Weighted Avg Shares Out Dil | 98 | 98 | 98 | 98 |
| Supplemental Information | – | – | – | – |
| Interest Income | $78 | $40 | $9 | $11 |
| Interest Expense | $15 | $13 | $13 | $14 |
| Depreciation & Amortization | $266 | $137 | $209 | $100 |
| EBITDA | $2,365 | $1,388 | $1,112 | $1,152 |
| % Margin | 33.5% | 24.3% | 21.7% | 24.9% |